Anti-ARHGAP6 antibody (480-560 aa) (STJ191324)

SKU:
STJ191324

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Rho GTPase-activating protein 6 (480-560 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
ELISA 1:5000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: ARHGAP6
Gene ID: 395
Uniprot ID: RHG06_HUMAN
Immunogen Region: 480-560 aa
Specificity: RHG06 Polyclonal Antibody detects endogenous levels of protein.
Immunogen: Synthesized peptide derived from the human protein at the amino acid range 480-560
Function GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Could regulate the interactions of signaling molecules with the actin cytoskeleton. Promotes continuous elongation of cytoplasmic processes during cell motility and simultaneous retraction of the cell body changing the cell morphology.
Protein Name Rho Gtpase-Activating Protein 6
Rho-Type Gtpase-Activating Protein 6
Rho-Type Gtpase-Activating Protein Rhogapx-1
Database Links Reactome: R-HSA-8980692
Reactome: R-HSA-9013423
Cellular Localisation Cytoplasm
Alternative Antibody Names Anti-Rho Gtpase-Activating Protein 6 antibody
Anti-Rho-Type Gtpase-Activating Protein 6 antibody
Anti-Rho-Type Gtpase-Activating Protein Rhogapx-1 antibody
Anti-ARHGAP6 antibody
Anti-RHOGAP6 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance